MODIFIED TAURINE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES CONTAINING SAME
The present invention relates to modified taurine, and a pharmaceutical composition or food composition, containing the same as an active ingredient, for preventing or treating metabolic diseases. More specifically, the modified taurine of the present invention, which has different physical features...
Saved in:
| Main Author | |
|---|---|
| Format | Patent |
| Language | English French Korean |
| Published |
23.06.2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to modified taurine, and a pharmaceutical composition or food composition, containing the same as an active ingredient, for preventing or treating metabolic diseases. More specifically, the modified taurine of the present invention, which has different physical features from the existing taurine, has a remarkable effect of preventing and treating metabolic syndromes, including an antithrombotic effect.
Cette invention concerne une taurine modifiée, et une composition pharmaceutique ou une composition alimentaire la contenant à titre de principe actif destinée à prévenir ou à traiter des maladies métaboliques. Plus spécifiquement, la taurine modifiée selon l'invention, qui présente des caractéristiques physiques différentes de la taurine existante, a un effet remarquable de prévention et de traitement des syndromes métaboliques, y compris un effet anti-thrombotique.
본 발명은 변성 타우린, 및 이를 유효성분으로 포함하는 대사질환 예방 또는 치료용 약학조성물 또는 식품조성물에 관한 것으로, 더욱 상세하게는 기존의 타우린과 상이한 물리적 성격을 갖는 본원 발명의 변성 타우린을 통하여 항혈전 효과를 포함하는 대사증후군의 예방 및 치료에 현저한 효과가 있다. |
|---|---|
| AbstractList | The present invention relates to modified taurine, and a pharmaceutical composition or food composition, containing the same as an active ingredient, for preventing or treating metabolic diseases. More specifically, the modified taurine of the present invention, which has different physical features from the existing taurine, has a remarkable effect of preventing and treating metabolic syndromes, including an antithrombotic effect.
Cette invention concerne une taurine modifiée, et une composition pharmaceutique ou une composition alimentaire la contenant à titre de principe actif destinée à prévenir ou à traiter des maladies métaboliques. Plus spécifiquement, la taurine modifiée selon l'invention, qui présente des caractéristiques physiques différentes de la taurine existante, a un effet remarquable de prévention et de traitement des syndromes métaboliques, y compris un effet anti-thrombotique.
본 발명은 변성 타우린, 및 이를 유효성분으로 포함하는 대사질환 예방 또는 치료용 약학조성물 또는 식품조성물에 관한 것으로, 더욱 상세하게는 기존의 타우린과 상이한 물리적 성격을 갖는 본원 발명의 변성 타우린을 통하여 항혈전 효과를 포함하는 대사증후군의 예방 및 치료에 현저한 효과가 있다. |
| Author | BYUN, JONGHYUN |
| Author_xml | – fullname: BYUN, JONGHYUN |
| BookMark | eNqNi8sKwjAURLPQha9_CLhVaFUKXV6TW3uhSUqS6rIUiStJC_X_sYof4GrmMGeWbBb7GBYsKiOpIJTcQ2NJ446DlrwuwSoQ2HgSUHFhVG0ceTKaF8by2uIVtSd94RN5i_DtCj2cTUWCS3IIDt301B5If1YHCtds_uieY9j8csW2BXpR7sPQt2EcunuI4dXezCFJsyTP01MG6fE_6w29JzoX |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | TAURINE MODIFIÉE, ET COMPOSITION PHARMACEUTIQUE DESTINÉE À PRÉVENIR OU À TRAITER DES MALADIES MÉTABOLIQUES LA CONTENANT 변성 타우린 및 이를 포함하는 대사질환 예방 또는 치료용 약학조성물 |
| ExternalDocumentID | WO2016099146A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_WO2016099146A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 15:18:58 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French Korean |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_WO2016099146A13 |
| Notes | Application Number: WO2015KR13789 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160623&DB=EPODOC&CC=WO&NR=2016099146A1 |
| ParticipantIDs | epo_espacenet_WO2016099146A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20160623 |
| PublicationDateYYYYMMDD | 2016-06-23 |
| PublicationDate_xml | – month: 06 year: 2016 text: 20160623 day: 23 |
| PublicationDecade | 2010 |
| PublicationYear | 2016 |
| RelatedCompanies | BYUN, JONGHYUN |
| RelatedCompanies_xml | – name: BYUN, JONGHYUN |
| Score | 3.0212328 |
| Snippet | The present invention relates to modified taurine, and a pharmaceutical composition or food composition, containing the same as an active ingredient, for... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | MODIFIED TAURINE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES CONTAINING SAME |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160623&DB=EPODOC&locale=&CC=WO&NR=2016099146A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU_FjSkDpk8V27Tr7MCRrUhexaemyubexzhRE6Yar-O97qZv6tLckR47k4D5-Se6C0LXrOY52y2ae3SnT9VXH9MErmO7MdtXUVy9TT-c7R8LrD93HcXtcQ-_rXJiqTuhXVRwRNGoG-l5W9nrxd4hFq7eVy9vsFYbm96HsUmOFjm0Ix1uOQXtdlsQ0DowgANxmiPSHBrGQ6xHASls6kNaV9tmop_NSFv-dSriPthPgV5QHqPY2b6DdYP33WgPtRKsrb2iutG95iIoopjzkjGJJhikX7AYTQXHSJ2lEAjaUurYBDuIoiQdcHz1hgHgYZDxiQnLxgKEnU0aqdsQk6cVPPMCUDxgBswozhSRcaOqAROwIXYVMBn0TFj75ldPkOf6_S-cY1Yt5oU4QtrI887M8t5y242YQ1CnLVlO71VIAfpTVOUXNTZzONpPP0Z7u6vdTLaeJ6uXHp7oAT11ml5WAvwEvK43q |
| link.rule.ids | 230,309,786,891,25594,76904 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG-IGvFNUeMHahPNnlzcF8M9EFO2zlVZt4yCvBGGJTEaIDLjv-91gvLEW9tLL-0l17vftXdF6MZxbVuZZX2S30vd8WRT98Aq6M7YdOTIk68jV-U7x9yNes7ToDGooI9VLkxZJ_S7LI4IGjUGfS_K83r-H8QKyreVi7v8DYZmD6FoBdoSHZvgjlu2FrRbNE2CxNd8H3CbxrNfGvhCjksAK203ARSqSvu031Z5KfN1oxLuo50U-E2LA1R5n9VQ1V_9vVZDu_HyyhuaS-1bHKJpnAQsZDTAgvQyxuktJjzAaUSymPi0J1RtA-wncZp0mQo9YYB4GGTcp1ww_oihJzJKynZMBWknHebjgHUpgWMVZnJBGFfULonpEboOqfAjHRY-_JPT8CVZ36V9jLams6k8QdjIJ7mXTyaG3bCdHJw6aZhyZFqWBPAjjeYpqm_idLaZfIWqkYg7ww7jz-doT5HUWyrLrqOt4vNLXoDVLvLLUtg_-J2Q1Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MODIFIED+TAURINE%2C+AND+PHARMACEUTICAL+COMPOSITION+FOR+PREVENTING+OR+TREATING+METABOLIC+DISEASES+CONTAINING+SAME&rft.inventor=BYUN%2C+JONGHYUN&rft.date=2016-06-23&rft.externalDBID=A1&rft.externalDocID=WO2016099146A1 |